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Abstract
Familial hyperkalemic hypertension (FHHt) is a rare inherited form of salt-
dependent hypertension caused by mutations in proteins that regulate the
renal Na+-Cl- cotransporter NCC. Mutations in four genes have been reported
to cause FHHt including CUL3 (Cullin3) that encodes a component of a
RING E3 ligase. Cullin-3 binds to WNK kinase-bound KLHL3 (the substrate
recognition subunit of the ubiquitin ligase complex) to promote ubiquitina-
tion and proteasomal degradation of WNK kinases. Deletion of exon 9 from
CUL3 (affecting residues 403-459, CUL3D403-459) causes a severe form of
FHHt (PHA2E) that is recapitulated closely in a knock-in mouse model. The
loss of functionality of CUL3D403-459 and secondary accumulation of WNK
kinases causes substantial NCC activation. This accounts for the hypertension
in FHHt but the origin of the hyperkalemia is less clear. Hence, we explored
the impact of CUL3D403-459 on expression of the distal secretory K channel,
ROMK, both in vitro and in vivo. We found that expressing wild-type but
not the CUL3D403-459 mutant form of CUL3 prevented the suppression of
ROMK currents by WNK4 expressed in Xenopus oocytes. The mutant CUL3
protein was also unable to affect ROMK-EGFP protein expression at the sur-
face of mouse M-1 cortical collecting duct (CCD) cells. The effects of CUL3
on ROMK expression in both oocytes and M-1 CCD cells was reduced by
addition of the neddylation inhibitor, MLN4924. This confirms that neddyla-
tion is important for CUL3 activity. Nevertheless, in our knock-in mouse
model expressing CUL3D403-459 we could not show any alteration in ROMK
expression by either western blotting whole kidney lysates or confocal micro-
scopy of kidney sections. This suggests that the hyperkalemia in our knock-in
mouse and human PHA2E subjects with the CUL3D403-459 mutation is not
caused by reduced ROMK expression in the distal nephron.
Introduction
The WNK kinases are a family of serine/threonine kinases
that are expressed in the mammalian kidney, and
mutations in them can cause Gordon’s syndrome
(http://omim.org/entry/145260), also known as pseudohy-
poaldosteronism type 2 (PHA2) or Familial Hyperkalemic
Hypertension (FHHt). These kinases connect the aldos-
terone signaling pathway to renal Na+ and K+ transporters
by regulating the membrane expression of the NaCl trans-
porter (NCC) and the renal outer-medullary K+ channel
KCNJ1 (ROMK). The WNK kinases achieve this by form-
ing a signaling cascade with downstream kinases, SPAK
(SPS1-related proline/alanine-rich kinase) and OSR1
(oxidative stress–responsive kinase 1), which in turn phos-
phorylate and activate SLC-type cation-chloride cotrans-
porters in the kidney, such as NCC, leading to an increased
sodium ion reabsorption (Richardson et al. 2008, 2011;
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Delpire and Gagnon 2008) and hence hypertension due to
the salt retention. Subjects with FHHt also have abnormali-
ties in other electrolyte flux pathways showing typically
hyperkalemia and metabolic acidosis, that is only partly
driven by NCC activation (McCormick et al. 2014; Boyden
et al. 2012; Glover et al. 2014; Osawa et al. 2013; Tsuji
et al. 2013).
WNK4 has a master regulator role, regulating both the
balance between NaCl reabsorption and K+ secretion in
the kidney. In FHHt, the kidney constitutively reabsorbs
NaCl at the expense of an impaired K+ secretory pathway
(Golbang et al. 2005; Kahle et al. 2003) causing the
hyperkalemic hypertension. WNK1, WNK3 and WNK4
inhibit the ROMK activity directly by regulating its
expression at the cell surface. This is achieved by stimu-
lating an endocytosis pathway involving clathrin-coated
vesicles (Cope et al. 2006; Welling 2016). The single chan-
nel conductance and open/closed probability of ROMK
channels are not affected (Leng et al. 2006). Phosphoryla-
tion of WNK4 at Ser1196 by serum/glucocorticoid-
induced kinase 1 (SGK1) also blocks the inhibitory action
of WNK4 on ROMK. This effect by SGK1 is diminished
by the Src-family protein tyrosine kinase (SFK), which
phosphorylate WNK4 and modulate its inhibitory effect
on ROMK (Lin et al. 2015).
More recently, mutations in Kelch-like3 (KLHL3) and
Cullin3 (CUL3), components of an E3 ubiquitin ligase
complex, were found to cause FHHt (PHA2D http://omi
m.org/entry/614495 and PHA2E http://omim.org/entry/
614496) (Boyden et al. 2012; Louis-Dit-Picard et al.
2012). Although mutations in the WNK kinases, KLHL3
or CUL3 cause the same disease, recent reports (Tsuji
et al. 2013; Boyden et al. 2012; Osawa et al. 2013) have
shown genotype–phenotype differences. Specifically, CUL3
mutations cause an earlier onset and a more severe form
of the disease (PHA2E) in terms of both the hypertension
and hyperkalemia. All the PHA2E-causing mutations in
CUL3 reported to date, are heterozygous, transmit as
autosomal dominant traits and cause splicing defects that
delete the amino acids encoded for by exon 9 of the
CUL3 mRNA (residues 403–459) (Boyden et al. 2012;
Glover et al. 2014; Grimm et al. 2012; Osawa et al. 2013;
Tsuji et al. 2013).
Using a knock-in mouse model of PHA2E, we have
reported recently the molecular basis for the effects of the
exon 9-deleted form of CUL3 (Schumacher et al. 2015).
This has also suggested that a vascular component could
be contributing to the hypertension in addition to the salt
retention caused by NCC activation in the DCT. How-
ever, the basis for the hyperkalemia was not explored and
this forms the basis for this study. Since ROMK is the
principal K+ secreting channel in the kidney, we have
studied the effect of the CUL3 mutation on the WNK4
regulation of this channel using both in vitro and in vivo
approaches.
Materials and Methods
Expression in Xenopus oocytes
All experimentation with Xenopus frogs was carried out
in accordance with welfare guidance from the UK Home
Office. Xenopus laevis oocytes were harvested and defollic-
ulated, and cRNA synthesized as detailed previously (Gol-
bang et al. 2005). Briefly, 50 ng of ROMK (KCNJ1)
cRNA alone was injected or ROMK in combination with
respective cRNAs for WNK4, CUL3 wild-type (WT)/
CUL3D403-459 and KLHL3 WT as the case may be, were
coinjected in a total volume of 50 nL per oocyte (The
plasmid constructs were a generous gift from Prof. D
Alessi, University of Dundee). The cRNA for each of
them was run off from the linearized plasmid construct
(WNK4 in pTNT, CUL3 WT and mutant forms in pDNA
3.1 and KLHL3 WT in pTLN vector) using the T7 mMes-
sage mMachine Transcription Kit (Ambion http://
www.thermofisher.com/). After injection, oocytes were
incubated in HEPES-buffered ND96 containing 2 mmol/L
sodium pyruvate and 0.1 mg/mL gentamicin at 18°C for
2–3 days before use.
Two-electrode voltage clamp recording
The methods used have been reported previously in detail
(Murthy et al. 2014; Golbang et al. 2005). Water-injected
oocytes were used as controls throughout. In experiments
where MLN4924 (https://www.caymanchem.com/) a small
molecule inhibitor of Cullin3 neddlylation was tested, the
oocytes were pretreated to a final concentration of
1 lmol/L and DMSO-treated oocytes were tested as the
vehicle control.
Cell culture
M-1 CCD cells (a generous gift from Prof JM Edwardson,
Department of Pharmacology, University of Cambridge)
were grown in standard DMEM/Ham’s F12 media with
2.5 mmol/L L-glutamine adjusted to contain 15 mmol/L
HEPES, 0.5 mmol/L sodium pyruvate and 1.2 g/L sodium
bicarbonate supplemented with 0.005 mmol/L dexam-
ethasone (www.sigmaaldrich.com) and 5% fetal bovine
serum at 37°C in 5% CO2–95% air atmosphere, and
transfected using Lipofectamine 2000 (Invitrogen Tech-
nologies, https://www.thermofisher.com/) with ROMK-
EGFP alone, or they were cotransfected with WNK4. 24 h
post transfection, the cells expressing the ROMK-EGFP
and WNK4 were further split into 10 cm plates and
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transfected with various combinations of CUL3-FLAG
WT/exon 9 deleted CUL3-FLAG and KLHL3-FLAG WT
as the case may be. Cells expressing ROMK-EGFP with
WNK4, CUL3 WT, and KLHL3 WT were treated with
3.5 lmol/L MLN4924 for 12 h.
Biotinylation
Transfected M-1 CCD cells in 10 cm plates were biotiny-
lated following a previously published method (Hardege
et al. 2015). Briefly, M-1 CCD cells in 10 cm plates were
washed once in NES and placed on ice. Cells were incu-
bated in 0.2 mg/mL NHS- biotin (www.thermofisher.com)
for 45 min on ice before quenching with Tris buffer
(25 mmol/L Tris-HCl; 150 mmol/L NaCl; 10 mmol/L
EDTA, pH 7.4). Cells were removed from the plate and
centrifuged at 200 g for 5 min at 4°C. Supernatant was dis-
carded and cells incubated in solubilization buffer
(25 mmol/L Tris-HCl; 150 mmol/L NaCl; 10 mmol/L
EDTA; 1% Triton X-100, pH7.4) with protease inhibitors
(www.roche.co.uk) at 4°C with agitation for 1 h. The
resulting lysate was cleared by centrifugation at 18,000 g
rpm 4°C for 1 h. 30 lL of streptavidin beads (www.ther-
mofisher.com) per sample was washed once in wash buffer
(25 mmol/L Tris-HCl; 150 mmol/L NaCl; 10 mmol/L
EDTA; 1% Triton X-100, pH 7.4), centrifuged at 1800 g for
5 min at 4°C and supernatant removed. The supernatant
was added to streptavidin beads and incubated with agita-
tion for 2 h at 4°C. Beads were then pelleted at 18,000 g for
5 min at 4°C and washed three times in wash buffer before
resuspending the pellet in sample buffer (www.lifetechnolo-
gies.com).
Western blotting
Cells were harvested 48 h post plasmid transfection,
and they were lysed in 400 lL RIPA lysis buffer supple-
mented with protease inhibitors, phosphatase inhibitors,
and 1 mmol/L DTT. After protein quantification by
BCA method, 15 lg equivalent total protein lysate was
loaded on to 3–8% Tris-acetate Nupage gel and trans-
ferred to nitroceullulose membranes. When studying
ROMK levels in transfected cells, streptavidin beads
bound to biotinylated protein were resuspend in sample
buffer before loading on gels. Membranes were Ponceau
stained to check for transfer efficiency and loading, and
blocked with 5% milk for 1 h and incubated with pri-
mary antibody in 5% (w/v) skimmed milk in TBS-T
with the indicated primary antibodies: 1 lg/mL WNK4-
total antibody (residues 1221–1243 of human WNK4,
S064B) (Division of Signal Transduction Therapy Unit,
University of Dundee) or 2 lg/mL rabbit anti-KCNJ1
antibody which is C-terminal directed, (Atlas
antibodies) and Living Colors monoclonal Antibody
(JL-8) (Clontech) overnight at 4°C. The blots were then
washed three times with TBS-T and incubated for 1 h
at room temperature with secondary HRP-conjugated
antibodies diluted 10,000-fold in 5% (w/v) skimmed
milk in TBS-T. After repeating the washing steps, the
signal was detected with enhanced chemiluminescence
reagent.
Immunostaining
Mouse kidney sections on glass slides were prepared for
immunostaining according to a previously published pro-
tocol (Schumacher et al. 2015). They were then blocked
for 2 h at room temperature with 2% (v/v) donkey serum
in 0.05% (v/v) Triton X-100–PBS. Primary antibodies
were incubated overnight for 20 h at 4°C at the following
concentrations diluted in 1% (v/v) donkey serum in
0.05% (v/v) Triton X-100–PBS: 2 lg/mL for ROMK
(https://atlasantibodies.com/), 2 lg/mL for total NKCC2
(Division of Signal Transduction Therapy Unit, University
of Dundee), and 0.2 lg/mL for Aquaporin2 (AQP2 anti-
body, Santa Cruz Biotechnology). Two negative controls
were processed, one where the primary antibody was
absent whereas the secondary antibody was added, and
vice-versa for the second negative control. The former
served as a control for autofluorescence due to the sec-
ondary antibody. Slides were then washed for 15 min in
0.05% (v/v) Triton X-100–PBS and incubated in sec-
ondary antibody for 2 h in a humid environment. Pre-
absorbed donkey IgG-conjugated Alexa Fluor 568 and 633
secondary antibodies (https://www.thermofisher.com/and
http://www.abcam.com/) were used at 1:200 diluted in
1% (v/v) donkey serum in 0.05% (v/v) Triton X-100–PBS
for immunofluorescent labeling. Slides were washed as
mentioned earlier and mounted using vectashield with
DAPI (Vector labs).
Image acquisition and processing
Immunofluorescent images were acquired on the Leica
Sp5 ultrahigh speed inverted confocal microscope with
488-, 543-, 633-nm laser lines mounted on an upright
Leica DM RXA fluorescent microscope using an HC PL
FLUOTAR 20X/0.5NA objective. Acquisition parameters
were: 12-bit, 1024 9 1024 pixels, 2 9 digital zoom,
400 Hz scan speed, sequential (by line) channel imaging
and 10 slice z-stack of 5 lm. In FIJI image analysis soft-
ware (http://fiji.sc/), fluorescent z-stacks underwent back-
ground subtraction (1000px radius rolling ball, no
smoothing) and average intensity z-projection. Brightness
and contrast were adjusted by linear histogram stretching
only to enhance visibility. Comparison kidney images for
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the CUL3D403-459/+ and WT CUL3+/+ mouse were
processed together using identical image settings.
Immunoblotting of mouse kidney lysates
All animal studies and breeding was approved by the
University of Dundee ethical committee and performed
under a UK Home Office approved project license. Snap
frozen kidneys from CUL3+/+ and CUL3D403-459 mice were
sliced into quarters, and one of the quarters was homoge-
nized using a TissueLyser LT (https://www.qiagen.com/
#85600) and protein lysates were extracted in RIPA lysis
buffers containing protease and phosphatase inhibitors
(https://www.roche.co.uk/ #11836170001 & #04906845001).
All steps were carried out at 4°C. Protein concentrations
were determined with the PierceTM BCA protein assay
(https://www.thermofisher.com/#23225). 10 lg equivalent
protein lysates were immunoblotted with the rabbit anti-
KCNJ1 antibody (https://atlasantibodies.com/) at 2 lg/mL
concentration in 5% (w/v) skimmed milk in TBS-T. Sec-
ondary antibodies (donkey anti rabbit 800CW (926–32213
at 1:5000 dilution; www.licor.com) and goat anti mouse
Alexa680 (A-21058 at 1:5000 dilution; www. lifetechnolo-
gies.com) were incubated in TBS-Tween for 1 h at room
temperature in the dark, then washed 6X in TBS-Tween.
Membranes were imaged and integrated intensity values
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Figure 1. (A) The current–voltage (I–V) plot for voltage-clamped Xenopus oocytes expressing Ba-sensitive currents. ROMK expressed either
alone (■), or ROMK with: WNK4 (▲) or WNK4 + KLHL3 WT (●). Mean  sem (n = 6), *P < 1E6 vs ROMK + WNK4. (B) The current–voltage
(I–V) plot for voltage-clamped Xenopus oocytes expressing Ba-sensitive currents. ROMK expressed either alone (■), or ROMK with: WNK4 (▲)
WNK4 + CUL3 WT (●), WNK4 + CUL3D403-459 (♦). Mean  sem (n = 6), *P < 1E6 versus CUL3. (C) The current–voltage (I–V) plot for
voltage-clamped Xenopus oocytes (expressing Ba-sensitive currents either ROMK alone (■), or ROMK with: WNK4 (▲), WNK4 + CUL3
WT + KLHL3 WT(●), WNK4 + CUL3 WT + KLHL3 WT + 1 lmol/L MLN 4924 (♦). Mean  sem (n = 6), *P < 1E6 versus absence of MLN
4924. (D) The current–voltage (I–V) plot for voltage-clamped Xenopus oocytes expressing Ba-sensitive currents. ROMK expressed either alone
(■), or ROMK with: WNK4 (♦), WNK4 + CUL3 WT (●), WNK4 + CUL3D403-459 (▲) or WNK4 + CUL3 WT + CUL3D403-459 (▼). Mean  sem
(n = 6), *P < 1E6 versus CUL3 alone. (E) The current–voltage (I–V) plot for voltage-clamped Xenopus oocytes expressing Ba-sensitive currents.
ROMK expressed either alone (■), or with CUL3 WT + KLHL3 WT (▲),or CUL3D403-459 + KLHL3 WT (▼). Mean  sem (n = 5), No significant
differences observed between the three different treatments.
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quantified (bands were normalized against b-actin) using
the LiCor odessey system (www.licor.com) or using IMAGE
J software (http://imagej.net).
Statistical analysis
All data are shown as mean  SEM unless indicated
otherwise. Significance was determined using unpaired t
test or one-way ANOVA followed by post hoc testing as
appropriate. P < 0.05 was considered significant. The stats
package in Prism4 (http://www.graphpad.com/scientific-
software/prism/) was used. In the plotting of the I–V
plots with this package the points are simply connected
point-to-point and not fitted to any curve.
Results
Wild-type CUL3 and KLHL3 abrogate WNK4
inhibition of ROMK currents
To explore the effect of CUL3 and KLHL3 on WNK4 reg-
ulation of ROMK expression, we coexpressed WNK4 and
ROMK in Xenopus oocytes. In the absence of coexpressed
CUL3 or KLHL3, WNK4 produced the expected reduc-
tion in ROMK current, whereas KLHL3 WT significantly
reduced the WNK4 inhibition of ROMK currents
(Fig. 1A). CUL3 or KLHL3 had no effect on ROMK cur-
rents in the absence of WNK4 (Fig. 1E). We found that
CUL3 wild-type (WT) completely abolished the effect of
WNK4 on the inward component of ROMK currents, but
the CUL3D403-459 mutant was ineffective (Fig. 1B). The
combination of CUL3 and KLHL3 WT had a similar
effect on the currents as the individual WT proteins, and
pre-treatment of the oocytes with MLN4924 (Fig. 1C),
partially restored the WNK4 inhibition of ROMK.
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Figure 2. (A) Effect of CUL3 on the WNK4 protein levels in the
mouse M-1 CCD cell line. Total protein lysates were blotted from
M-1 CCD cells transfected with ROMK alone (far left) or ROMK
with the constructs indicated. Lane 5 (far right) is a control where
WNK4 has not been transfected into the cells. Anti-WNK4 antibody
(residues 1221–1243 of human WNK4, S064B) detected a 150 KDa
WNK4 band. b-actin was the loading control. This is representative
of Western blots replicated three times with cell lysates from three
different passage numbers. (B) Quantification of Western blots
showing WNK4 levels normalized to its b-actin loading control.
Error bars represent mean  sem of Western blots (n = 3).
*P < 0.0001 by one-way ANOVA.
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Figure 3. (A) Effect of CUL3 on the biotinylated ROMK-EGFP levels
in the M-1 CCD cell line. Total protein lysates were blotted from
M-1 CCD cells transfected with ROMK-EGFP alone or ROMK-EGFP
with constructs indicated. Anti-KCNJ1 antibody detected a band at
around 75 KDa for ROMK-EGFP. This is representative Western
blots replicated 3 times with cell lysates from three different
passage numbers. (B) Quantification of Western blots showing
ROMK levels in biotinylated cell lysates. Error bars represent
mean  sem of Western blots (n = 3). *P < 0.05.
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MLN4924 is a small molecule inhibitor of NEDD8-acti-
vating enzyme, (NAE), that inactivates Cullin-RING E3
ubiquitin Ligases (CRLs) by blocking their NAE-depen-
dent neddylation. Of note, the effect of the CUL3D403-459
mutant was more pronounced than WT CUL3 alone
when they were coexpressed with ROMK and WNK4,
leading to a further decrease in ROMK currents
(Fig. 1D). This suggests that the CUL3D403-459 mutant
form of CUL3 functions as a dominant-negative on CUL3
WT.
WNK4 is a substrate for the CUL3-KLHL3
complex in vitro
To study the effect of the CUL3-KLHL3 complex on
WNK4 protein abundance, ROMK-EGFP, WNK4, and
KLHL3 WT were coexpressed with CUL3 WT or the
CUL3D403-459 mutant form, respectively, in a mouse corti-
cal cell line (M-1 CCD). Low endogenous WNK4 levels
were detectable in transfected M-1 cells but were mark-
edly increased by transfection (Fig. 2). Coexpression of
WT CUL3 with KLHL3 substantially reduced the level of
immunoblottable WNK4, but the CUL3D403-459 mutant
was much less effective (Fig. 2).
The M-1 cells were then biotinylated to measure ROMK
channel protein expressed at cell surface. Western blotting
with the anti-KCNJ1 antibody showed that the surface
expression of ROMK moved in parallel with the variations
in WNK4 levels in the transfected M-1 cells (Fig. 3).
WNK4 significantly reduced the ROMK-EGFP levels as
compared to ROMK-EGFP alone. In cells expressing CUL3
WT, the ROMK-EGFP levels were restored whereas this
salvage effect of CUL3 was greatly reduced in CUL3D403-459
mutant expressing cells, emphasizing the contrasting
effects of the WT and CUL3D403-459 mutant form of CUL3
on WNK4 levels. To further investigate the effect of CUL3
on WNK4 levels in M1 CCD cells, the CUL3 WT trans-
fected cells were treated with the NEDD8-activating
enzyme inhibitor, MLN4924 to block neddylation and acti-
vation of the CUL3-ligase complex. In keeping with the
effect of this inhibitor on ROMK currents in oocytes
(Fig. 1C), ROMK-EGFP levels were markedly reduced in
the MLN4924-treated M-1 cells (Fig. 4), showing the
importance of CUL3 Neddylation for its effect on WNK4
degradation and hence ROMK-EGFP expression.
ROMK expression in vivo in the
CUL3D403-459/+ mouse
To establish if expression of the CUL3D403-459 mutant
form of CUL3 was able to alter expression of ROMK
in vivo, we studied our recently characterized knock- in
CUL3D403-459/+ mouse. This mouse recapitulates closely
the human PHA2E phenotype including its hyperkalemia.
Using confocal immunofluorescent staining we identified
ROMK in the cortical collecting ducts (CCD), where it
co-localized with AQP2, connecting tubules (CNT), and
the thick ascending limb (TAL) in the medulla of these
mice (Fig. 5). ROMK also colocalized with NKCC2 in the
TAL as expected. However, there were no obvious differ-
ences in either the intensity or distribution of the staining
in CUL3D403-459/+ mouse versus the WT CUL3+/+ litter-
mate controls. Immunoblotting whole kidney lysates also
failed to identify any differences in ROMK abundance in
the CUL3D403-459/+ in keeping with the results of the
immunohistochemical staining (Fig. 6).
Discussion
We recently reported a knock-in mouse model in which
heterozygous expression of CUL3D403-459 recapitulates clo-
sely the human PHA2E phenotype (Schumacher et al.
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Figure 4. (A) Effect of CUL3 on the biotinylated ROMK-EGFP levels
in the presence of WNK4 in a mouse cortical collecting duct cell
line (M1 CCD). (A) Total protein lysates were blotted from M-1 cells
transfected with ROMK-EGFP alone or ROMK-EGFP with the
constructs indicated. The last combination was also treated with
3.5 lmol/L MLN4924. Anti-KCNJ1 antibody detected a band at
around 75 KDa for ROMK-EGFP. This is representative of Western
blots replicated with three different passage numbers. (B)
Quantification of Western blot showing ROMK levels in biotinylated
cell lysates. Error bars represent mean  sem of three Western
blots. *P < 0.05 by one-way ANOVA.
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2015). Molecular modeling further suggested that the
deletion of exon 9 (residues 403–459) increased structural
flexibility of the CUL3 protein that affected its scaffolding
function. Specifically, mutant CUL3 binds to the RBX1
protein to form a ubiquitin E3 ligase, but the complex
cannot effectively degrade KLHL3-bound substrates such
as WNK4 (Schumacher et al. 2015). Instead, CUL3D403-459
auto-ubiquitylates and loses its interaction with two
important Cullin regulators: the COP9-Signalosome and
CAND1. The defective ubiquitylation of WNKs led to
substantial accumulation in the kidney of WNK4 and its
downstream components, SPAK and NCC (both their
total and phosphorylated forms). This scenario provided
an explanation for the hypertension in the mice, but it
was unclear whether it also explained the hyperkalemia.
Our previous work on WNK kinase regulation of
ROMK showed that WNK1 reduces surface expression of
ROMK in Xenopus oocytes by stimulating internalization
of the channel through a pathway involving clathrin-
coated vesicles (Cope et al. 2006). An identical mecha-
nism is reported to operate for WNK4 at least in cultured
mammalian cells (Kahle et al. 2003). Hence, our working
hypothesis was that WNK4 accumulation in the kidney of
the CUL3D403-459 mouse could be sufficient to cause sub-
stantial reduction of ROMK expression in the distal
nephron. This loss of ROMK from the luminal membrane
would in turn provide an explanation for the hyper-
kalemia seen in our knock-in mouse.
The studies reported here in Xenopus oocytes confirms
that overexpression of the WNK4 is able to substantially
reduce ROMK currents. We further show that this effect
is abolished by coexpression of CUL3 protein but not by
expressing the CUL3D403-459 mutant. This presumably
reflects the ability of CUL3 (but not the mutant) to form
an active Cullin-RING-ligase with Xenopus paralogs of
Kelch-like3, which ubiquitylates the overexpressed WNK4
causing its endosomal degradation. This is supported by
the effect of MLN4924, an inhibitor of CUL3 Neddyla-
tion. In the presence of MLN4924, the ability of CUL3
WT to reverse the effect of WNK4 on ROMK current was
lost, showing that ubiquitylation through an active RING-
ligase is indeed necessary for the action of CUL3 in these
experiments.
Coexpressing CUL3 WT and the CUL3D403-459 mutant
in the oocytes did not restore the ROMK currents sug-
gesting that the mutant behaves as a dominant negative
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Figure 5. Immunostaining of ROMK (green) and AQP2 (red) in the cortex and apical immunostaining of ROMK (green) and total NKCC2 (red)
in the medulla of CUL3D403-459/+ kidney versus littermate controls CUL3+/+. These are representative pseudocolored average intensity z-
projections of immunofluorescent-stained kidney sections (4 per genotype) and four independent immunostaining experiments, showing the
distribution of total protein. Colocalization is in orange. Scale bar = 30 lm.
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in this system. This contrasts with our earlier published
findings in mammalian HEK cells, where we speculated
that the CUL3D403-459 mutant may cause haploinsuffi-
ciency because of its extensive removal by auto-degrada-
tion. However, our observations here are supported by
other recent studies which have also suggested that the
CUL3D403-459 mutant behaves as a dominant negative
being more effective than the CUL3 WT in reducing the
abundance of the WNK4 adaptor, KLHL3 (Araki et al.
2015; Ibeawuchi et al. 2015; McCormick et al. 2014).
Hence, the mutant might effectively increase WNK4
abundance by degrading the endogenous paralogs of
KLHL3 in Xenopus oocytes.
Our findings in the oocytes were replicated in the
mouse M-1 CCD cells where we have blotted WNK4 to
confirm its predicted accumulation in the presence of the
CUL3D403-459 mutant. An increase in WNK4 levels in the
presence of CUL3 mutant led to a corresponding decrease
in the abundance of biotinylated ROMK in M-1 cells.
This confirms that the accumulated WNK4 is able to alter
the abundance of ROMK at the cell surface of CCD cells,
and vice-versa. To see if the mechanism actually operates
in vivo we looked at ROMK expression in the kidneys of
our CUL3D403-459/+ mice and compared them with
CUL3+/+ littermates. However, it was obvious from con-
focal images of immunostained kidney sections that that
there were no convincing differences in ROMK levels in
the CNT, TAL or the CCD of the two genotypes. Further-
more, there were no differences detectable by
immunoblotting whole kidney lysates from the two geno-
types. It is possible, however, that significant differences
in vivo ROMK currents have gone undetected. This is
technically challenging to perform but could be measured
by ex vivo patch clamping of CD tubules. Alternatively
differences may be uncovered by altering dietary K or
measuring the saluretic responses amiloride challenge
(Hadchouel et al. 2010).
Clearly, the knock-in mouse does not recapitulate
in vivo the reduced ROMK expression seen in vitro
despite high WNK4 levels in both systems. In fact in the
kidney of the CUL3D403-459/+ mice the excess WNKs (and
downstream signaling components) accumulate to form
discrete puncta within the cytosol (Schumacher et al.
2015). Nevertheless, mouse models of FHHt have gener-
ally not reported on ROMK expression in vivo to provide
a comparison for our observations. One exception is a
mouse showing kidney-specific knock-out of WNK1 that
was reported to have modified ROMK staining in the
DCT and CNT (Hadchouel et al. 2010). However, this
was based only on a visual impression and the authors
commented that there was marked variability between
animals and tubules in the intensity of apical staining.
The same group also reported reduced expression of
ROMK of mice overexpressing WNK1-LS in the DCT.
Again the data relied on a visual comparison of confocal
images (Vidal-Petiot et al. 2013). No attempt was made
to follow this visual impression with quantification such
as western blotting. The mouse could, of course, become
hyperkalemic secondary to the high levels of NCC activity
in the DCT reducing electrogenic Na transport in the
CCD. This would reduce the potential difference needed
to drive K secretion by ROMK channels regardless of
their expression level. It is also possible that other mecha-
nisms operate to reduce K secretion. For example, recent
studies have shown that BK channels are involved in
flow-induced K+ secretion in the distal nephron and are
regulated by WNK4 in an in vitro system (Wang et al.
2013). This study indicated that WNK4 inhibits BK chan-
nel activity partly by degradation of the channel protein
through an ubiquitin-dependent pathway. Hence, WNK4
accumulation could directly suppress BK expression and
this forms the subject of future investigations.
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